IL-31, Human
| $180.00 | |
| Z02717-10 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
| $180.00 | |
| Z02717-10 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
| Species | Human | |
| Protein Construction |
|
|
| Purity |
> 97% as analyzed by SDS-PAGE > 97% as analyzed by HPLC |
|
| Endotoxin Level | < 1 EU/μg of protein by LAL method | |
| Biological Activity | Fully biologically active when compared to standard. The specific activity is determined by inducing STAT3 activation using human U-87 MG cells. 5.0 ng/ml of rHuIL-31 can effectively induce STAT3 activation. | |
| Expression System | E. coli | |
| Theoretical Molecular Weight | 15.8 kDa | |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS, pH 7.4. | |
| Reconstitution | It is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/ml. | |
| Storage & Stability | Upon receiving, this product remains stable for 6 months at -70°C or -20°C. Upon reconstitution, the product should be stable for 1 week at 4°C or for 3 months at -20°C. Avoid repeated freeze-thaw cycles. |
| Target Background | Human IL-31 is a T-cell derived cytokine that shares several structural and functional characteristics with IL-6, Oncostatin M, LIF, and Cardiotrophin-1. It signals through a receptor complex comprised of GPL (GP130-like, IL-31RA) and OSMR (Oncostatin M receptor). GPL/OSMR signaling is a strong activator of STAT3 and STAT5, and can also activate STAT1, Jak1, and Jak2 signaling pathways. IL-31 regulated immune responses have been implicated in skin physiology and inflammatory skin diseases. |
| Synonyms | IL31; IL-31; interleukin 31 |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.